Last reviewed · How we verify
Cravit based triple therapy
Cravit based triple therapy is a Small molecule drug developed by National Taiwan University Hospital. It is currently FDA-approved.
At a glance
| Generic name | Cravit based triple therapy |
|---|---|
| Sponsor | National Taiwan University Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Efficacies of Susceptibility-guided vs Empiric Therapy for Rescue Treatment of Helicobacter Pylori Infection (PHASE4)
- Efficacy and Safety of Basic Triple Therapy Including Ilaprazole on the First Line Eradication Treatment of H.Pylori
- Comparison of the Efficacy of Levofloxacin-based Sequential Therapy and Triple Therapy as Second Line Therapy (PHASE4)
- Levofloxacin Versus Clarithromycin Triple Therapy in First-Line Treatment for Helicobacter Pylori Eradication (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Cravit based triple therapy CI brief — competitive landscape report
- Cravit based triple therapy updates RSS · CI watch RSS
- National Taiwan University Hospital portfolio CI
Frequently asked questions about Cravit based triple therapy
What is Cravit based triple therapy?
Cravit based triple therapy is a Small molecule drug developed by National Taiwan University Hospital.
Who makes Cravit based triple therapy?
Cravit based triple therapy is developed and marketed by National Taiwan University Hospital (see full National Taiwan University Hospital pipeline at /company/national-taiwan-university-hospital).
What development phase is Cravit based triple therapy in?
Cravit based triple therapy is FDA-approved (marketed).
Related
- Manufacturer: National Taiwan University Hospital — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing